Hangzhou Tigermed Consulting Co., Ltd. (abbreviated “Tigermed”) has issued a notice convening its 2026 First H Share Class Meeting. The session will take place on 2 June 2026 at the company’s Hangzhou headquarters, immediately after the conclusion of the 2025 annual general meeting and the 2026 first A Share class meeting.

Key agenda • Special Resolution: Grant a general mandate authorising the Board to repurchase H Shares. Approval requires at least two-thirds of the voting rights held by H-shareholders (including proxies) present at the meeting.

Eligibility and timetable • Share register closure: 28 May – 2 June 2026 (both days inclusive). • Record date: H-shareholders on the register as of 2 June 2026 may attend and vote. • Share transfer deadline: 16:30 on 27 May 2026 at Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.

Voting arrangements • Poll voting will be adopted. • Each eligible H-shareholder may appoint one or more proxies; forms of proxy must reach Tricor Investor Services Limited at least 24 hours before the meeting. • Corporate shareholders must execute proxies under seal or by authorised signatory. • Attendees must present identity documents; travel and accommodation costs are borne by shareholders or their proxies.

Board composition (as at 30 April 2026) • Executive Directors: Dr. Ye Xiaoping (Chairman), Ms. Cao Xiaochun, Mr. Wu Hao, Mr. Wen Zengyu. • Independent Non-executive Directors: Mr. Liu Kai Yu Kenneth, Mr. Yuan Huagang, Ms. Liu Yuwen.

The company has not provided further details on the scale or timing of potential H-share repurchases; these will depend on shareholder approval of the mandate.